Korro Bio (KRRO) Change in Account Payables (2018 - 2026)
Korro Bio (KRRO) posted Change in Account Payables of -$153000.0 for Q1 2026, up 75.98% on a QoQ basis from -$637000.0 in Q4 2025, and down 254.55% year-over-year from $99000.0 in Q1 2025.
Korro Bio (KRRO) Change in Account Payables (2018 - 2026) Analysis & Trends
Korro Bio's Change in Account Payables history runs 9 years deep, the most recent figure standing at -$153000.0 for Q1 2026.
- Quarterly Change in Account Payables fell 254.55% year-over-year to -$153000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.6 million (down 290.84% YoY) and the FY2025 annual result came in at -$2.3 million, down 72.33% from the prior year.
- Change in Account Payables was -$153000.0 for Q1 2026 at Korro Bio, up from -$637000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.8 million in Q4 2023 and bottomed at -$2.9 million in Q3 2025.
- A 5-year average of $61764.7 and a median of -$153000.0 in 2026 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2024 — Change in Account Payables jumped 1128.71% — and 2025, when it plunged 1152.4%.
- Korro Bio's Change in Account Payables stood at $1.3 million in 2022, then jumped by 115.35% to $2.8 million in 2023, then tumbled by 121.68% to -$605000.0 in 2024, then decreased by 5.29% to -$637000.0 in 2025, then jumped by 75.98% to -$153000.0 in 2026.
- Business Quant data shows KRRO's Change in Account Payables at -$153000.0 in Q1 2026, -$637000.0 in Q4 2025, and -$2.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -42.19 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 16.86 Mn |
| 10 | Korro Bio | 123.70 Mn | 9.73 Mn | - | -153,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -153,000.00 |
| Mar 31, 2026 | -153,000.00 |
| Dec 31, 2025 | -637,000.00 |
| Dec 31, 2025 | -637,000.00 |
| Sep 30, 2025 | -2.87 Mn |
| Sep 30, 2025 | -2.87 Mn |
| Jun 30, 2025 | 1.10 Mn |
| Jun 30, 2025 | 1.10 Mn |
| Mar 31, 2025 | 99,000.00 |
| Mar 31, 2025 | 99,000.00 |
| Dec 31, 2024 | -605,000.00 |
| Dec 31, 2024 | -605,000.00 |
| Sep 30, 2024 | -229,000.00 |
| Sep 30, 2024 | -229,000.00 |
| Jun 30, 2024 | 2.08 Mn |
| Jun 30, 2024 | 2.08 Mn |
| Mar 31, 2024 | -2.59 Mn |
| Mar 31, 2024 | -2.59 Mn |
| Dec 31, 2023 | 2.79 Mn |
| Dec 31, 2023 | 2.79 Mn |